BioVie Inc.
BIVI
$1.46
$0.053.55%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -23.52% | 10.43% | -11.11% | -19.67% | 12.29% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.13% | 28.20% | -23.53% | -61.35% | -16.95% |
| Operating Income | 14.13% | -28.20% | 23.53% | 61.35% | 16.95% |
| Income Before Tax | 14.66% | -22.53% | 29.38% | 65.44% | 15.34% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 14.66% | -22.53% | 29.38% | 65.44% | 15.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.66% | -22.53% | 29.38% | 65.44% | 15.34% |
| EBIT | 14.13% | -28.20% | 23.53% | 61.35% | 16.95% |
| EBITDA | 14.24% | -28.60% | 23.82% | 61.81% | 17.06% |
| EPS Basic | 83.17% | 85.94% | 76.77% | 92.46% | 79.31% |
| Normalized Basic EPS | 83.07% | 84.96% | 76.77% | 91.63% | 79.44% |
| EPS Diluted | 83.09% | 85.94% | 76.77% | 92.47% | 79.31% |
| Normalized Diluted EPS | 83.07% | 84.96% | 76.77% | 91.63% | 79.44% |
| Average Basic Shares Outstanding | 403.96% | 715.00% | 204.01% | 313.10% | 311.76% |
| Average Diluted Shares Outstanding | 403.96% | 715.00% | 204.01% | 313.10% | 311.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |